Antares Pharma Inc. (AIS) Profile

Profile for Antares Pharma Inc. (AIS)

After Hours: $ 2.59

0.00 (0.00%)

Volume: 4.54 k

5:15 PM EST Feb 10, 2012


Business Description: Antares Pharma, Inc. develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral disintegrating tablets and reusable needle-free and disposable pressure assisted auto injector and pen injector systems.

Address:	250 Phillips Bloulevard, Suite 290, Ewing, NJ, 08618
Telephone:	(609) 359-3020	Website:	www.antarespharma.com
Facsimile:	(610) 458-0756	Email:	info@antarespharma.com


Details

CEO:	Dr. Paul K. Wotton,PhD
Employees:	21	Market Cap:	268.1 m
Issue Type:	CS
Auditor:	KPMG LLP
Last Audit:	Unqualified
Indices:	Medical Instruments & Supplies


Industry Classifications

Sector:	Healthcare	CIK:	0001016169
Industry:	Health Services
Sub-Industry:	Medical Instruments & Supplies
NAICS:	Surgical and Medical Instrument Manufacturing (339112)
SIC:	Surgical And Medical Instruments And Apparatus (3841)

Tags for Antares Pharma Inc.

Research stocks or mutual funds related to Antares Pharma Inc. by keywords or tags. Find companies that have a similar focus to AIS. The keywords below have been associated to AIS by either user submission or electronic means.

pharmaceuticals research pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceuticals logistics new drug delivery systems antares pharmaceutical research and development dupont pharmaceuticals pharma marketing pharma industry research pharmaceutical software pharma manufacturing pharma license pfizer pharmaceutical company generic products drug delivery pharma companies ap pharma andrx company pharma consulting pharmaceutical sales pharma consultants pharma drug delivery market pharma in licensing Surgical and Medical Instrument Manufacturing (339112) pharmaceutical development topical drug delivery pharma meeting pharma product development pharma r&d pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical manufacturing pharmaceutical formulation pharma reports pharma stocks pharmaceutical industry pharma distribution pharmaceutical studies pharmaceutical advances pharmaceutical out licensing pharmaceutical business development Healthcare pharmaceutical sector bio pharmaceuticals pharmaceutical pharma sales drug delivery systems

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.